Blog

May 3, 2017

Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia

Summary: BACKGROUND: Tetrahydrocannabinol (THC) is a potential treatment for Alzheimer’s disease (AD). OBJECTIVE: To measure efficacy and safety of medical cannabis oil (MCO) containing THC as […]
May 3, 2017

CBD: a promising drug for neurodegenerative disorders?

Summary: Neurodegenerative diseases represent, nowadays, one of the main causes of death in the industrialized country. They are characterized by a loss of neurons in particular […]
May 3, 2017

The therapeutic potential of the endocannabinoid system for Alzheimer’s disease.

Summary:  Dementia currently affects over 35 million people worldwide. The most common form of dementia is Alzheimer’s disease (AD). Currently, treatments for AD do not stop […]
May 3, 2017

CBD for the Treatment of Agitation and Aggression in Alzheimer’s Disease.

Summary: Alzheimer’s disease (AD) is frequently associated with neuropsychiatric symptoms (NPS) such as agitation and aggression, especially in the moderate to severe stages of the illness. […]
May 3, 2017

CBD regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders.

Summary: Learning to associate cues or contexts with potential threats or rewards is adaptive and enhances survival. Both aversive and appetitive memories are therefore powerful drivers […]
May 3, 2017

CBD Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway

Summary: Schizophrenia-related psychosis is associated with disturbances in mesolimbic dopamine (DA) transmission, characterized by hyperdopaminergic activity in the mesolimbic pathway. Currently, the only clinically effective treatment […]
May 3, 2017

CBD reduces cigarette consumption in tobacco smokers: preliminary findings.

Summary: The role of the endocannabinoid system in nicotine addiction is being increasingly acknowledged. We conducted a pilot, randomised double blind placebo controlled study set out […]
May 3, 2017

CBD in clinical practice.

Summary: Cannabis has a potential for clinical use often obscured by unreliable and purely anecdotal reports. The most important natural cannabinoid is the psychoactive tetrahydrocannabinol (delta9-THC); […]